Abbott helps people live fully through life-changing technology that makes you healthier. As a global leader in diabetes care, Abbott is constantly working to deliver the highest quality products and unwavering support to our customers. Consistent and accurate glucose monitoring is the foundation of any diabetes management plan so we’re committed to continuous improvement in the way patients and professionals measure, track and analyse glucose levels.

    Abbott has provided a comprehensive range of blood glucose monitoring systems for people with diabetes for more than 20 years. In more recent years, Abbott has entered the sensor-based glucose monitoring device market with its revolutionary FreeStyle Libre flash glucose monitoring system which allows a user to monitor their glucose levels without fingerpricks while providing a much more complete view of glucose profile over time. Clinical studies have been performed to demonstrate benefits to the user in terms of improving their glucose control (Novel Glucose-Sensing Technology and Hypoglycaemia in Type 1 Diabetes: A Multicentre Non-masked, Randomised Controlled Trial (IMPACT), Lancet, Bolinder, J. et al, Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicentre, open-label, randomised controlled trial (REPLACE), Diabetes Therapy, Haak, T. et al).

    Main tasks within the project will be to support the collation of clinical study data to establish a pooled and harmonised database as part of WP3, where Abbott will be represented as an industry co-lead. Abbott will also be an industry co-lead for WP5 where potential clinical studies will be discussed.

    Chris Bennell, BSc, CStat, ADC Statistics and Analysis Manager, Abbott Diabetes Care

    In his current role, Chris is responsible for the management of a team of statisticians, programmers and data managers in providing statistical support for new product development and global clinical trials and studies for Abbott’s diabetes care division. Chris has been with Abbott since 2003, serving in his current role for six years.

    Chris received his BSc in Mathematics and Statistics from University of Kent at Canterbury and is a member of the Royal Statistical Society.

    Alexander Seibold, MD, Regional Medical Director of Europe and Middle East, Diabetes Care, Abbott

    Alexander Seibold oversees the Medical Affairs activities in Europe, Middle East, Africa and Pakistan. His main objective is to facilitate the development and implementation of new concepts in diabetes care based on the insights to the glucose metabolism, FreeStyle Libre is providing. As a young physician, Alexander did his specialized training in internal medicine, endocrinology and diabetology. In his clinical work as well his research, Alexander has always focused on diabetes mellitus. He has held various positions in Medical Affairs, Sales and General Management in Europe with global responsibility. Alexander joined Abbott in May 2016. Alexander conducted his doctoral thesis at the University of Ulm, Germany.

    Mahmood Kazemi, MD, Divisional Vice President of Global Medical and Scientific Affairs, Diabetes Care, Abbott

    Dr. Mahmood Kazemi is ADC’s Divisional Vice President of Global Medical & Scientific Affairs. Mahmood has been with ADC since 2015 after two years as Medical Director at Sanofi. Prior to that appointment, Mahmood was in private endocrinology practice for six years while also serving as Assistant Clinical Professor of Medicine at UCSF’s Division of Diabetes. Mahmood earned his Bachelors and Masters degrees from Stanford University, and his medical degree from UCSF. Mahmood coordinates ADC medical affairs activities around the world. He provides medical support for educational activities as well as scientific communications and discussions with key opinion leaders and payers.

    Joe Bugler, BSc, Senior Director of Clinical Development and Regulatory Affairs, Diabetes Care, Abbott

    Joe has been with Abbott’s diabetes care division since 1991 where he has held a number of positions within the clinical and regulatory affairs group both in the UK and the U.S. In his current role, Joe oversees the activities of this division for the EMEA region.

    Joe is a member of the European Association for the Study of Diabetes, the American Diabetes Association and the Institute for Clinical Research and Regulatory Affairs Professionals Society. He received his BSc in Applied Biology from University of Plymouth and an MSc in Human and Applied Physiology from Kings College, London.

    Dr Pamela Reid, Director of Clinical Affairs and Technical Support, Europe and Middle East, Diabetes Care, Abbott

    Pamela Reid, PhD, manages both statistics and clinical operations teams for Abbott’s diabetes care business across the EMEA region, where she is responsible for the oversight and management of multiple, concurrent clinical trials from study design/conception through to results publication.

    Pamela worked in the biochemical manufacturing industry before transitioning to IVDD/medical devices, specializing in the field of diabetes and glucose monitoring. She has had various scientific roles within R&D before moving into clinical affairs and has been with Abbott’s diabetes care business for 21 years. Pamela received her PhD in Chemical Engineering from Queen’s University Belfast and her BSc (Hons) in Applied Biochemistry from University of Paisley, Scotland.